The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, involves a complex several-stage chemical process. Initial routes focused on amino acid chain fragment coupling, utilizing https://aadamgvxi683208.snack-blog.com/40919288/synthesis-and-investigation-implementations-of-retatrutide